Total Payments
$6,978
2024 Payments
$1,520
Companies
28
Transactions
445
Medicare Patients
772
Medicare Billing
$65,329
Payment Breakdown by Category
Food & Beverage$6,958 (99.7%)
Education$20.33 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,958 | 440 | 99.7% |
| Education | $20.33 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,181 | 77 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $742.99 | 55 | $0 (2022) |
| Alkermes, Inc. | $677.27 | 44 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $588.75 | 33 | $0 (2024) |
| Lundbeck LLC | $558.41 | 34 | $0 (2024) |
| ABBVIE INC. | $535.27 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $361.55 | 26 | $0 (2024) |
| Corium, LLC | $303.60 | 14 | $0 (2024) |
| ITI, Inc. | $237.09 | 13 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $220.55 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,520 | 92 | Lundbeck LLC ($304.17) |
| 2023 | $1,276 | 78 | ABBVIE INC. ($230.87) |
| 2022 | $1,136 | 63 | Sunovion Pharmaceuticals Inc. ($161.96) |
| 2021 | $810.89 | 49 | Sunovion Pharmaceuticals Inc. ($167.11) |
| 2020 | $513.67 | 32 | Teva Pharmaceuticals USA, Inc. ($353.27) |
| 2019 | $813.26 | 58 | Sunovion Pharmaceuticals Inc. ($224.93) |
| 2018 | $692.21 | 57 | Alkermes, Inc. ($272.04) |
| 2017 | $216.86 | 16 | Allergan Inc. ($108.56) |
All Payment Transactions
445 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.98 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $34.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: ADHD | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Central Nervous System | ||||||
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 325 | 370 | $37,715 | $26,042 |
| 2022 | 2 | 79 | 126 | $9,975 | $6,132 |
| 2021 | 3 | 114 | 157 | $14,899 | $9,708 |
| 2020 | 6 | 254 | 470 | $39,898 | $23,447 |
Total Patients
772
Total Services
1,123
Medicare Billing
$65,329
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 58 | 58 | $11,600 | $8,643 | 74.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 141 | $12,690 | $7,930 | 62.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 84 | 93 | $6,510 | $5,101 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $4,550 | $3,023 | 66.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 43 | $2,365 | $1,346 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 87 | $7,830 | $4,650 | 59.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 39 | $2,145 | $1,482 | 69.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 50 | $6,435 | $4,645 | 72.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 85 | $7,254 | $4,347 | 59.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 22 | $1,210 | $715.73 | 59.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 116 | $9,283 | $6,565 | 70.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 40 | 180 | $8,100 | $5,283 | 65.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 67 | $8,375 | $3,954 | 47.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 40 | $6,200 | $3,368 | 54.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 45 | 52 | $4,940 | $2,897 | 58.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $3,000 | $1,378 | 45.9% |
About Dr. Nestor Praderio, M.D
Dr. Nestor Praderio, M.D is a Geriatric Psychiatry healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144265562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nestor Praderio, M.D has received a total of $6,978 in payments from pharmaceutical and medical device companies, with $1,520 received in 2024. These payments were reported across 445 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,958).
As a Medicare-enrolled provider, Praderio has provided services to 772 Medicare beneficiaries, totaling 1,123 services with total Medicare billing of $65,329. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Psychiatry
- Other Specialties Psychiatry
- Location Corpus Christi, TX
- Active Since 06/19/2006
- Last Updated 11/01/2023
- Taxonomy Code 2084P0805X
- Entity Type Individual
- NPI Number 1144265562
Products in Payments
- REXULTI (Drug) $1,061
- AUSTEDO (Drug) $908.51
- LATUDA (Drug) $742.99
- VRAYLAR (Drug) $596.50
- CAPLYTA (Drug) $354.85
- ARISTADA (Drug) $345.85
- Aristada 441 mg (Drug) $295.42
- Austedo XR (Drug) $272.40
- TRINTELLIX (Drug) $235.49
- Azstarys (Drug) $194.37
- Dyanavel XR (Drug) $190.02
- NUEDEXTA (Drug) $184.87
- Auvelity (Drug) $164.61
- HETLIOZ (Drug) $164.06
- NUPLAZID (Drug) $153.08
- BELSOMRA (Drug) $126.09
- INVEGA TRINZA (Drug) $113.69
- VYVANSE (Drug) $108.86
- NAMZARIC (Drug) $108.56
- Adlarity (Drug) $97.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.